Time-resolved proteomic characterization of microglia in APP/PS1 and APP-KI mouse models of AD revealed dynamic alterations in the expression of fatty acid transporters FABP3 and FABP5 that correlated with advanced Aβ deposition and decline in microglial functions [104]. Here, APP is linked to Alzheimer disease.